Delivery of Doxorubicin from Hyaluronic Acid-Modified Glutathione-Responsive Ferrocene Micelles for Combination Cancer Therapy-Reference-Cited by-同舟云学术

Delivery of Doxorubicin from Hyaluronic Acid-Modified Glutathione-Responsive Ferrocene Micelles for Combination Cancer Therapy

Published:2019-01-09 Issue:3 Volume:16 Page:987-994
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Mao Hong-Lin¹²,Qian Feng¹²,Li Shun¹²,Shen Jia-Wei¹²,Ye Cheng-Kun¹²,Hua Lei¹²,Zhang Long-Zhen³⁴,Wu Dong-Mei⁵,Lu Jun⁵,Yu Ru-Tong¹²^ORCID,Liu Hong-Mei¹²^ORCID

Affiliation:

1. Institute of Nervous System Diseases, Xuzhou Medical University, Xuzhou 221002, P.R. China

2. Brain Hospital, Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, P.R. China

3. Department of Radiation Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, P.R. China

4. Cancer Institute of Xuzhou Medical University, Xuzhou 221002, P.R. China

5. Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province School of Life Science, Jiangsu Normal University, Xuzhou 221116, P.R. China

Funder

China Postdoctoral Science Foundation

Natural Science Foundation of Jiangsu Province

Government of Jiangsu Province

National Natural Science Foundation of China

Jiangsu Provincial Commission of Health and Family Planning

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.8b00862